CN109646514A - Longan leaf extract and the preparation method and application thereof - Google Patents

Longan leaf extract and the preparation method and application thereof Download PDF

Info

Publication number
CN109646514A
CN109646514A CN201710948747.3A CN201710948747A CN109646514A CN 109646514 A CN109646514 A CN 109646514A CN 201710948747 A CN201710948747 A CN 201710948747A CN 109646514 A CN109646514 A CN 109646514A
Authority
CN
China
Prior art keywords
extract
ethyl acetate
longan leaf
alcohol
longan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201710948747.3A
Other languages
Chinese (zh)
Inventor
梁洁
黄春燕
徐晖
杨川川
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangxi University of Chinese Medicine
Original Assignee
Guangxi University of Chinese Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangxi University of Chinese Medicine filed Critical Guangxi University of Chinese Medicine
Priority to CN201710948747.3A priority Critical patent/CN109646514A/en
Publication of CN109646514A publication Critical patent/CN109646514A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/77Sapindaceae (Soapberry family), e.g. lychee or soapberry
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50Methods involving additional extraction steps
    • A61K2236/55Liquid-liquid separation; Phase separation

Abstract

The invention discloses extract that the extract with alpha-glucosidase activity is inhibited is prepared from longan leaf, the extract is that longan leaf is extracted with EtOH Sonicate after crushed, ethanol extract is condensed into medicinal extract after ethyl alcohol is recovered under reduced pressure, add water that medicinal extract is suspended, the ethyl acetate extract being successively obtained by extraction with petroleum ether, ethyl acetate;And after being extracted with ethyl acetate, then the n-butanol extract obtained with extracting n-butyl alcohol.Show that the active component has through pharmacological experiment study and inhibit alpha-glucosidase activity well, wherein the effect with ethyl acetate extract becomes apparent.The present invention uses abundance, and cheap longan leaf is raw material, provides more extensive Remedies for diabetes source, has good social value and economic value, plays an important role to the hypoglycemic drug for developing efficient, safe.

Description

Longan leaf extract and the preparation method and application thereof
Technical field
The present invention relates to the preparation of plant extracts and applied technical fields, and in particular to longan leaf extract and its preparation Method further relates to the application of longan leaf extract.
Background technique
With the variation of continuous improvement of people's living standards and dietary structure, diabetic increases year by year, glycosuria Disease has become " the third killer " that the mankind are threatened after cardiovascular disease and tumour, has become so preventing and treating diabetes For global problem.Diabetes are a kind of using hyperglycemia as the metabolic disorder disease of main feature, in pathogenic process most The symptom first occurred is usually postprandial hyperglycemia, i.e. the early stage sign of diabetes, especially Patients with NIDDM, postprandial high blood Sugar not only easily induces various complication, can also greatly improve the death rate of diabetes.Therefore, reducing postprandial blood sugar is prevention Diabetes reduce one of complication and the important measure of the reduction death rate.Blood glucose is mainly derived from carbohydrate and carbon water in food Compound can be by small intestinal absorption by catalyzing hydrolysis at monosaccharide under the action of alpha-glucosidase.Alpha-glucosidase is sugar Key enzyme in metabolic process, the effect for controlling alpha-glucosidase can effectively prevent carbohydrate in food and carbohydrate turns It is melted into monosaccharide and is absorbed, and then reduce blood glucose level.Alpha-glucosidase restrainer mainly passes through inhibition alpha-glucosidase Activity, the absorption of delay glucose in vivo reduce blood glucose.Therefore, alpha-glucosidase restrainer is currently used for clinic Oral hypoglycemic agents, such drug clinically has acarbose, voglibose and Miglitol at present.Existing phlorose Glycosides enzyme inhibitor type is less, and there are certain gastrointestinal side effects, or even can cause certain serious side effects, because This, safer and more effective natural alpha-glucosidase restrainer requires study exploitation.
Longan leaf is Chinese medicine simply with Guangxi national characters, is recorded in " this sketch of the southern regions of the Yunnan Province is said " earliest.It is famous Subtropical fruit -- longan (Dimocarpus longan Lour.) tree leaf or tender shoots.Its nature and flavor is sweet, light, flat, has Deliver the primary efficacies such as heat-clearing, eliminating damp, detoxifying.It is mainly used for treating cold, fever, malaria, furunculosis, eczema etc..Longan originates in The south subtropics region of south China and North Vietnam has more than 2000 years cultivation histories in China.China's Longan Cultivation area It occupies first place in the world with yield.South China longan leaf resource reserves are abundant, after annual longan is plucked, orchard worker to trees into Row lopping, a large amount of leaf are abandoned or burn, and result in waste of resources and environmental pollution.Longan leaf mainly contains tannin, phenolic acid The ingredients such as class, flavonoids and volatile oil.Although existing research shows that longan leaf has apparent hypoglycemic, the pharmacology such as anti-oxidant Effect, but it is less about the research report of longan leaf hypoglycemic effect both at home and abroad, and invention once carried out research to its blood sugar reducing function. The domestic research to longan leaf is reported few at present, in terms of the extraction for being concentrated mainly on flavones ingredient, is had no and is dropped blood for it Sugared active component or extract extract separation method.Therefore, how by longan leaf play hypoglycemic effect activity at Divide and extract, to make full use of China's longan leaf resource abundant, researchs and develops more natural alpha-glucosidases suppressions Preparation is to need the technical issues of conscientiously solving.
The disclosure of background above technology contents is only used for auxiliary and understands inventive concept and technical solution of the invention, not The prior art for necessarily belonging to present patent application shows above content in the applying date of present patent application in no tangible proof In the case where having disclosed, above-mentioned background technique should not be taken to the novelty and creativeness of evaluation the application.
Summary of the invention
The purpose of the present invention is to provide a kind of to extract preparation from longan leaf has inhibition alpha-glucosidase activity Extract and the preparation method and application thereof.
To achieve the above object, the technical solution adopted in the present invention is as follows:
A kind of longan leaf extract, which, which has, inhibits alpha-glucosidase activity.
Further, above-described longan leaf extract is extracted with EtOH Sonicate after crushed for longan leaf, and ethyl alcohol mentions It is condensed into medicinal extract after taking liquid that ethyl alcohol is recovered under reduced pressure, adds water that medicinal extract is suspended, the second being successively obtained by extraction with petroleum ether, ethyl acetate Acetoacetic ester extract;And after being extracted with ethyl acetate, then the n-butanol extract obtained with extracting n-butyl alcohol.
Further, above-described longan leaf extract, most preferably preferably ethyl acetate extract.
Further, above-described longan leaf extract, the concentration of alcohol are 50% ethyl alcohol to dehydrated alcohol.
The preparation method of longan leaf extract described in more than one, comprising the following steps:
S1. dry longan leaf is taken, is extracted after crushing with EtOH Sonicate, extracting solution obtains medicinal extract after ethyl alcohol is recovered under reduced pressure;
S2. add water to be suspended medicinal extract, successively extracted with petroleum ether, ethyl acetate, obtain acetic acid ethyl acetate extract;
S3. by acetic acid ethyl acetate extract recycling design, ethyl acetate extract is obtained.
The preparation method of above-described longan leaf extract, further comprising the steps of:
In step S2 S4. the water layer left after " successively being extracted with petroleum ether, ethyl acetate ", then with extracting n-butyl alcohol, obtain Butanol extraction liquid;
S5. by butanol extraction liquid recycling design, n-butanol extract is obtained.
Further, the preparation method of above-described longan leaf extract, the concentration of alcohol is under step S1 50% ethyl alcohol is to dehydrated alcohol.
Further, the preparation method of above-described longan leaf extract is extracted with EtOH Sonicate under step S1 Successively to be extracted with 95% ethyl alcohol, 50% EtOH Sonicate.
In the application of hypoglycemic aspect, the ethyl acetate extract, n-butanol extract exist above-described longan leaf The health care product or the application in terms of drug of preparation prevention or treatment diabetes.
In the application of hypoglycemic aspect, the ethyl acetate extract, n-butanol extract exist above-described longan leaf Preparing has the health care product for inhibiting alpha-glucosidase activity or the application in terms of drug.
The beneficial effects of the present invention are:
1, the raw material used in the present invention are leaf or the tender shoots of longan, and a large amount of longan leaf is discarded or fired in the prior art It burns, results in waste of resources and environmental pollution, the present invention turn waste into wealth, raw material sources are abundant, cheap.
2, the present invention is screened by modernization extraction separation method in conjunction with a large amount of pharmacological evaluations, preferably obtains having fine Inhibition alpha-glucosidase activity extract, extract activity is strong, good drug efficacy, and quality safety is controllable.
3, the longan leaf extract with suppression alpha-glucosidase activity provided by the invention can be prepared into drug or health care Product can facilitate clinical application.The preparation method of longan leaf extract provided by the invention simultaneously, operation is simple, prepares institute It is high to obtain extract yield, strong operability is suitble to industrialized production.
Detailed description of the invention
Fig. 1 is PNP standard curve.
Fig. 2 is that different extracts compare alpha-glucosaccharase enzyme inhibition activity.
Fig. 3 is influence of the different extract concentrations to alpha-glucosaccharase enzyme inhibition activity.
Specific embodiment
The invention will be further described combined with specific embodiments below, but does not limit the scope of the invention and apply Range: the one, preparation of longan leaf extract
Embodiment 1
The preparation method of longan leaf extract, comprising the following steps:
S1. dry longan leaf 10kg is taken, is successively extracted with 95% ethyl alcohol and 50% EtOH Sonicate after crushing, is filtered, is merged Extracting solution is condensed into medicinal extract after ethyl alcohol is recovered under reduced pressure;
S2. it takes medicinal extract that water is added to be suspended, successively respectively extracts 3 times with petroleum ether (60-90 DEG C), ethyl acetate, n-butanol, finally Remaining aqueous, obtains the corresponding extracting solution of each solvent;
S3. each position extracting solution is taken respectively, solvent is recovered under reduced pressure, and is concentrated, it is dry, longan leaf ligroin extraction is obtained, Longan leaf ethyl acetate extract, longan leaf n-butanol extract, longan leaf water extract.
Embodiment 2
The preparation method of longan leaf extract, comprising the following steps:
S1. dry longan leaf 10kg is taken, dehydrated alcohol ultrasonic extraction is used after crushing, extracting solution must soak after ethyl alcohol is recovered under reduced pressure Cream;
S2. it takes ethanol extract that water is added to be suspended, is successively respectively extracted 3 times with petroleum ether (60-90 DEG C), ethyl acetate, n-butanol, Obtain acetic acid ethyl acetate extract, n-butanol extracting liquid;
S3. it takes acetic acid ethyl acetate extract, n-butanol extracting liquid that solvent is recovered under reduced pressure respectively, is concentrated, it is dry, obtain longan leaf Ethyl acetate extract, longan leaf n-butanol extract.
Embodiment 3
The preparation method of longan leaf extract, comprising the following steps:
S1. dry longan leaf 10kg is taken, is extracted after crushing with 75% EtOH Sonicate, ethyl alcohol is recovered under reduced pressure in filtering, extracting solution Medicinal extract is obtained afterwards;
S2. it takes medicinal extract that water is added to be suspended, is successively respectively extracted 3 times with petroleum ether (30-60 DEG C), ethyl acetate, n-butanol, obtain second Acetoacetic ester extracting solution, n-butanol extracting liquid;
S3. it takes acetic acid ethyl acetate extract, n-butanol extracting liquid that solvent is recovered under reduced pressure respectively, is concentrated, it is dry, obtain longan leaf Ethyl acetate extract, longan leaf n-butanol extract.
Embodiment 4
The preparation method of longan leaf extract, comprising the following steps:
S1. dry longan leaf 10kg is taken, is extracted after crushing with 50% EtOH Sonicate, ethyl alcohol is recovered under reduced pressure in filtering, extracting solution Medicinal extract is obtained afterwards;
S2. it takes medicinal extract that water is added to be suspended, is successively respectively extracted 3 times, obtained with petroleum ether (90-120 DEG C), ethyl acetate, n-butanol Acetic acid ethyl acetate extract, n-butanol extracting liquid;
S3. it takes acetic acid ethyl acetate extract, n-butanol extracting liquid that solvent is recovered under reduced pressure respectively, is concentrated, it is dry, obtain longan leaf Ethyl acetate extract, longan leaf n-butanol extract.
Embodiment 5
The preparation method of longan leaf extract, comprising the following steps:
S1. dry longan leaf 10kg is taken, is extracted after crushing with 40% EtOH Sonicate, ethyl alcohol is recovered under reduced pressure in filtering, extracting solution Medicinal extract is obtained afterwards;
S2. it takes medicinal extract that water is added to be suspended, is successively respectively extracted 3 times with petroleum ether (60-90 DEG C), ethyl acetate, n-butanol, obtain second Acetoacetic ester extracting solution, n-butanol extracting liquid;
S3. it takes acetic acid ethyl acetate extract, n-butanol extracting liquid that solvent is recovered under reduced pressure respectively, is concentrated, it is dry, obtain longan leaf Ethyl acetate extract, longan leaf n-butanol extract.
Two, longan leaf inhibits the screening study experiment of alpha-glucosidase activity extract
1 instrument and material
Infinite M200PRO microplate reader;(the safe macro medical instrument in Shaoguan is limited for LRH-250-S constant temperature and humidity incubator Company);KQ-500DA Ultrasound Instrument (Kunshan Ultrasonic Instruments Co., Ltd.);HWS-24 electric-heated thermostatic water bath (Shanghai Qi Xinke Learn Instrument Ltd.);BSA224S electronic balance;96 microwell plates;Various pipettors and pipette tips;Alpha-glucosidase (G5003- 100UN Sigma company, lot number SLBS9070);P-nitrophenyl-α-D- glucopyranoside (PNPG, Sigma company, lot number BCBR9743V);P-nitrophenol (PNP, Tianjin great Mao chemical reagent factory, lot number: 20170301);Reduced glutathione (GSH, Sigma company, lot number 213E053);Acarbose (Acarbose, Beyer Co., Ltd, lot number BJ33686);Dimethyl sulfoxide (DMSO), natrium carbonicum calcinatum, potassium dihydrogen phosphate, dipotassium hydrogen phosphate are that analysis is pure.
2 methods
2.1 sample
Take the longan leaf ligroin extraction of the embodiment of the present invention 1, longan leaf ethyl acetate extract, longan leaf n-butanol Extract, longan leaf water extract, as sample.
The research of 2.2 alpha-glucosidase activities
Each extract of longan leaf is dissolved with DMSO, and is stored in 4 DEG C of refrigerators, Activity determination is enterprising in 96 microwell plates Row, reaction system are as follows: taking the 50 μ L of kaliumphosphate buffer of pH6.8, be separately added into 10 μ L of GSH, sample 10 μ L, 0.57U/mL Alpha-glucosidase 5 μ L, 37 DEG C of isothermal reaction 15min, addition concentration are 20 μ L of 20mmol/L PNPG, 37 DEG C of isothermal reactions 15min adds the NaCO that concentration is 0.2mol/L340 μ L of solution, measures OD value under 400nm wavelength, and each sample is parallel Measurement 5 times.Using acarbose as positive control, inhibiting rate is calculated as follows:
Inhibition of enzyme activity rate (%)=[ABlank-(ASample-ABackground)]/ABlank×100
Note: ABlank: the light absorption value of reaction is added in no sample;ASample: the light absorption value of example reaction is added;ABackground: no enzyme solution is added Light absorption value.Inhibiting rate is calculated, and finds out corresponding IC with SPSS22.0 software50Value.
The drafting of 2.3 standard curves
According to the reaction system of use, 1000 μm of ol/L PNP are configured with kaliumphosphate buffer (pH6.8), are diluted to respectively 400μmol/L,300μmol/L,200μmol/L,100μmol/L,80μmol/L,40μmol/L,20μmol/L,0μmol/L.Point Each 160 μ L of the PNP solution of 9 kinds of various concentrations is not taken, and 0.2mol/L NaCO is added380 μ L of solution is mixed, under 400nm wavelength OD value is measured, 3 groups is surveyed and is averaged.Using OD value as ordinate, PNP concentration is abscissa, does standard curve.
3 results
The drafting of 3.1 standard curves
The regression equation of PNP standard working curve is y=0.0072x+0.0989, R2=0.9995, illustrate PNP in 0 μ Good linear relationship is presented in mol/L~1000 μm ol/L and OD value.The result is shown in Figure 1.
The expression activitiy of 3.2 longan leaf difference extracts
As shown in Table 1, at the same concentration (0.5mg/ml), using acarbose as positive control, alpha-glucosidase suppression Activity Results processed show that longan leaf ethyl acetate extract, n-butanol extract inhibiting rate respectively reach 69.98% (IC50= 29.9mg/L), 67.02% (IC50=41mg/L), it is above 64.58% (IC of positive control drug acarbose50=73.8mg/ L).Longan leaf opposed polarity extract alpha-glucosaccharase enzyme inhibition activity is followed successively by ethyl acetate extract > positive fourth from big to small Alcohol extracting thing > acarbose > ligroin extraction > water extract.It the results are shown in Table 1 and Fig. 2.
The different extract alpha-glucosaccharase enzyme inhibition activities (n=5) of table 1
Influence of the 3.3 longan leaf difference extract different quality concentration to alpha-glucosaccharase enzyme inhibition activity
Influence of the longan leaf difference extract different quality concentration to alpha-glucosaccharase enzyme inhibition activity the result shows that, 4 Different extracts are in positive dose-effect relationship, i.e. dose dependent to alpha-glucosaccharase enzyme inhibition activity and concentration, and inhibitory activity is with dense Degree improves and enhances, and wherein the concentration of ethyl acetate extract is linearly to increase in 0.1~1mg/mL, when concentration increases to one Periodically, concentration only has very little variation.Within the scope of experimental concentration, the inhibiting rate of acarbose also increases with the increase of concentration, And inhibiting rate is higher than positive control inhibiting rate within this range for longan leaf ethyl acetate extract and n-butanol extract.As a result It is shown in Table 2 and Fig. 3.
Influence (n=5) of the 2 longan leaf difference extract various concentration of table to alpha-glucosaccharase enzyme inhibition activity
Through experiment it is found that in the opposed polarity extract of longan leaf, ethyl acetate extract and n-butanol extract It is stronger to alpha-glucosaccharase enzyme inhibition activity, it is eager to excel than the inhibiting effect of acarbose.
Three, influence of the embodiment of the present invention to alpha-glucosaccharase enzyme inhibition activity
On the basis of longan leaf inhibits the screening study experiment of alpha-glucosidase activity extract, the present invention is implemented The resulting ethyl acetate extract of example 1-5 and n-butanol extract compare research to alpha-glucosaccharase enzyme inhibition activity.
1 instrument and material
Inhibit the screening study experiment of alpha-glucosidase activity extract with longan leaf
2 methods
2.1 sample
Take the longan leaf ethyl acetate extract of 1-5 of the embodiment of the present invention, longan leaf n-butanol extract, as sample.
The research of 2.2 alpha-glucosidase activities
Inhibit the screening study experiment of alpha-glucosidase activity extract with longan leaf.
The drafting of 2.3 standard curves
Inhibit the screening study experiment of alpha-glucosidase activity extract with longan leaf.
3 results
The drafting of 3.1 standard curves
See that longan leaf inhibits the screening study experiment of alpha-glucosidase activity extract.
The influence to alpha-glucosaccharase enzyme inhibition activity of extract is compared in 3.2 embodiment 1-5
As shown in Table 3, at the same concentration (0.5mg/ml), using acarbose as positive control, alpha-glucosidase suppression Activity Results processed show that the ethyl acetate extract inhibiting rate of embodiment 1-4 respectively reaches 69.98% (IC50=29.9mg/L), 67.53% (IC50=37.7mg/L), 68.18% (IC50=30.3mg/L), 66.92% (IC50=50.1mg/L), it is above 64.58% (IC of positive control drug acarbose50=73.8mg/L), and the ethyl acetate extract inhibiting rate of embodiment 5 is 63.42% (IC50=79.2mg/L), it is lower than positive control drug acarbose.It the results are shown in Table 3.
Ethyl acetate extract alpha-glucosaccharase enzyme inhibition activity (n=5) in each embodiment of table 3
As shown in Table 4, at the same concentration (0.5mg/ml), using acarbose as positive control, alpha-glucosidase suppression Activity Results processed show that the n-butanol extract inhibiting rate of embodiment 1-4 respectively reaches 67.02% (IC50=41.0mg/L), 66.06% (IC50=51.0mg/L), 66.87% (IC50=44.5mg/L), 65.83% (IC50=61.3mg/L), it is above 64.58% (IC of positive control drug acarbose50=73.8mg/L), and the n-butanol extract inhibiting rate of embodiment 5 is 62.15% (IC50=85.3mg/L), it is lower than positive control drug acarbose.It the results are shown in Table 4.
N-butanol extract alpha-glucosaccharase enzyme inhibition activity (n=5) in each embodiment of table 4
It can be seen from the above result that the ethyl acetate extract and n-butanol extract of 1-4 of the embodiment of the present invention are to α-grape Glucoside inhibiting activity is relatively strong, is eager to excel than the inhibiting effect of acarbose, and the ethyl acetate extract of embodiment 5 and just Butanol extract is relatively lower than acarbose to alpha-glucosaccharase enzyme inhibition activity, illustrates the extract of 40% ethyl alcohol extraction to α- Glucosidase inhibitory active is lower, and the extract that 50% or more ethyl alcohol extracts is equal to alpha-glucosaccharase enzyme inhibition activity It is higher, therefore the ethyl alcohol of present invention selection 50% or more extracts.

Claims (10)

1. a kind of longan leaf extract, which is characterized in that the extract, which has, inhibits alpha-glucosidase activity.
2. longan leaf extract according to claim 1, which is characterized in that the extract is that longan leaf uses second after crushed Alcohol ultrasonic extraction, ethanol extract are condensed into medicinal extract after ethyl alcohol is recovered under reduced pressure, add water that medicinal extract is suspended, and successively use petroleum ether, second The ethyl acetate extract that acetoacetic ester is obtained by extraction;And after being extracted with ethyl acetate, then the n-butanol obtained with extracting n-butyl alcohol Extract.
3. longan leaf extract according to claim 2, which is characterized in that the extract is ethyl acetate extract.
4. longan leaf extract according to claim 2, which is characterized in that the concentration of alcohol is 50% ethyl alcohol to anhydrous Ethyl alcohol.
5. a kind of preparation method of longan leaf extract as described in claim 1, which comprises the following steps:
S1. dry longan leaf is taken, is extracted after crushing with EtOH Sonicate, extracting solution obtains medicinal extract after ethyl alcohol is recovered under reduced pressure;
S2. add water to be suspended medicinal extract, successively extracted with petroleum ether, ethyl acetate, obtain acetic acid ethyl acetate extract;
S3. by acetic acid ethyl acetate extract recycling design, ethyl acetate extract is obtained.
6. a kind of preparation method of longan leaf extract as claimed in claim 5, which is characterized in that further comprising the steps of:
In step S2 S4. the water layer left after " successively being extracted with petroleum ether, ethyl acetate ", then with extracting n-butyl alcohol, obtain positive fourth Alcohol extract liquor;
S5. by butanol extraction liquid recycling design, n-butanol extract is obtained.
7. the preparation method of longan leaf extract according to claim 5 or 6, which is characterized in that the concentration of alcohol is 50% ethyl alcohol is to dehydrated alcohol.
8. the preparation method of longan leaf extract according to claim 5 or 6, which is characterized in that use second under step S1 Alcohol ultrasonic extraction is successively to be extracted with 95% ethyl alcohol, 50% EtOH Sonicate.
9. longan leaf as described in claim 1 is in the application of hypoglycemic aspect, it is characterised in that: the ethyl acetate extracts The application of object, n-butanol extract in terms of the health care product or drug of preparation prevention or treatment diabetes.
10. longan leaf as described in claim 1 is in the application of hypoglycemic aspect, it is characterised in that: the ethyl acetate extracts The application of object, n-butanol extract in terms of preparing the health care product or drug with inhibition alpha-glucosidase activity.
CN201710948747.3A 2017-10-12 2017-10-12 Longan leaf extract and the preparation method and application thereof Pending CN109646514A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710948747.3A CN109646514A (en) 2017-10-12 2017-10-12 Longan leaf extract and the preparation method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710948747.3A CN109646514A (en) 2017-10-12 2017-10-12 Longan leaf extract and the preparation method and application thereof

Publications (1)

Publication Number Publication Date
CN109646514A true CN109646514A (en) 2019-04-19

Family

ID=66109850

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710948747.3A Pending CN109646514A (en) 2017-10-12 2017-10-12 Longan leaf extract and the preparation method and application thereof

Country Status (1)

Country Link
CN (1) CN109646514A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110433220A (en) * 2019-07-30 2019-11-12 浙江师范大学 The method of alpha-glucosidase restrainer is extracted from longan seed

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1903053A (en) * 2005-07-25 2007-01-31 王浩贵 Tea contg. longan tree leaves for treating cold
CN104351442A (en) * 2014-12-03 2015-02-18 大新县科学技术情报研究所 Longan leaf heat-clearing and detoxifying tea

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1903053A (en) * 2005-07-25 2007-01-31 王浩贵 Tea contg. longan tree leaves for treating cold
CN104351442A (en) * 2014-12-03 2015-02-18 大新县科学技术情报研究所 Longan leaf heat-clearing and detoxifying tea

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
梁洁等: "龙眼叶不同提取物降血糖的实验研究 ", 《时珍国医国药》 *
贤景春等: "龙眼核提取物的α-葡萄糖苷酶抑制活性体外实验的研究", 《食品科技》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110433220A (en) * 2019-07-30 2019-11-12 浙江师范大学 The method of alpha-glucosidase restrainer is extracted from longan seed

Similar Documents

Publication Publication Date Title
Nickavar et al. Evaluation of α-amylase inhibitory activities of selected antidiabetic medicinal plants
CN104546980B (en) A kind of bee pollen extract and its preparation and application
US20120309710A1 (en) Compound sea cucumber preparation and manufacturing method thereof
CN103054907B (en) Propolis flavonoid extractive and preparation method thereof
Chen et al. A new approach for obtaining trans-resveratrol from tree peony seed oil extracted residues using ionic liquid-based enzymatic hydrolysis in situ extraction
CN104688801B (en) A kind of complex enzyme combination ultrasound extracts the production technology of eucommia bark flavone from folium cortex eucommiae
CN105661556A (en) Herba cistanche dietary fibers and preparation method and application thereof
Pereira et al. Inhibition of α-glucosidase and hypoglycemic effect of stilbenes from the Amazonian plant Deguelia rufescens var. urucu (Ducke) AMG Azevedo (Leguminosae)
CN102304501A (en) Complex enzyme preparation and application and method thereof for extracting plant polysaccharides by using same
Ghosh et al. Molecular docking and inhibition studies of α-amylase activity by labdane diterpenes from Alpinia nigra seeds
CN113150179A (en) Tremella aurantialba polysaccharide extraction and preparation technology
CN111096983A (en) Phellinus igniarius phenolic extract with hypoglycemic activity and preparation and application thereof
CN109646514A (en) Longan leaf extract and the preparation method and application thereof
CN102492667A (en) Enzyme preparation, and application of same in extraction of phellodendron berberine and method thereof
CN101830881B (en) Enzyme-induced method for efficiently extracting toxifolin from larch processing leftover
CN101744227A (en) Method for extracting Cordyceps militaris sporocarp dietary fiber
CN101156908B (en) Application of argentina anserina extractive in preparation of alpha glycosidase enzymes inhibitors
Han et al. Ultrasound-assisted enzymatic extraction of Corni Fructus alpha-glucosidase inhibitors improves insulin resistance in HepG2 cells
CN105250342B (en) Ligularia virgaurea extract, preparation method thereof and application thereof in aspect of reducing blood sugar
CN105395927B (en) Highland barley bran extract is preparing the application in alpha-glucosidase activity inhibitor
CN107281255B (en) Robinia pseudoacacia leaf active part and preparation method and application thereof
CN105106357A (en) Method for preparing extract with alpha-glucosidase restraining effect
CN108603212A (en) Utilize the manufacturing method of the anthocyanin oligomer of the coenzyme from aspergillus bacterium
CN101856089B (en) Lespedeza bicolor Turcz. bee pollen polysaccharide oral liquid and preparation method thereof
CN105250343B (en) Artemisia sphaerocephala extract, preparation method thereof and application thereof in reducing blood sugar

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20190419